Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Would your patient benefit from a monoclonal antibody?

< BACK TO ARCHIVE


2022 Oct


J Fam Pract


http://www.ncbi.nlm.nih.gov/pubmed/36508563?dopt=Abstract


71


8

Would your patient benefit from a monoclonal antibody?

Authors

Would your patient benefit from a monoclonal antibody?
Campbell LS, Sbar ED
J Fam Pract. 2022 Oct; 71(8):E1-E8.
PMID: 36508563.

Abstract

These unique agents may be the answer when other treatments fail or are intolerable for patients with asthma, atopic dermatitis, hyperlipidemia, osteoporosis, or migraine headaches.
Read This Paper